(S)-4-Methyl-5,5-diphenyloxazolidin-2-one is a chiral oxazolidinone derivative. It serves as a versatile chiral auxiliary in asymmetric synthesis, particularly in the Evans aldol reaction. The compound's structure features a rigid, well-defined chiral environment provided by the 5,5-diphenyl-substituted oxazolidinone ring, which is crucial for inducing high diastereoselectivity in the formation of new stereocenters. Its primary application is in the synthesis of complex, enantiomerically pure molecules, especially in pharmaceutical research and development. It is used to prepare key intermediates for active pharmaceutical ingredients (APIs), including β-hydroxy carbonyl compounds and α-amino acids. The (S)-enantiomer is specifically employed to control the absolute stereochemistry of the final products. While its core use is as a chiral auxiliary in medicinal chemistry, making it a valuable pharmaceutical intermediate, it is also a fundamental building block in advanced organic synthesis laboratories. It is commercially available from fine chemical suppliers specializing in chiral reagents and synthetic building blocks.